Target Name: HSPD1
NCBI ID: G3329
Review Report on HSPD1 Target / Biomarker Content of Review Report on HSPD1 Target / Biomarker
HSPD1
Other Name(s): Mitochondrial matrix protein P1 | Chaperonin 60 | HuCHA60 | Heat shock 60kDa protein 1 (isoform 1) | chaperonin 60 | Heat shock protein 60 | epididymis secretory sperm binding protein | Chaperonin | Hsp60 | HSP60 | CH60_HUMAN | short heat shock protein 60 Hsp60s1 | HSP-60 | SPG13 | heat shock protein family D (Hsp60) member 1 | Heat shock protein family D (Hsp60) member 1, transcript variant 1 | P60 lymphocyte protein | 60 kDa heat shock protein, mitochondrial | heat shock 60kDa protein 1 (chaperonin) | HSPD1 variant 1 | 60 kDa chaperonin | HSP65 | heat shock protein 65 | GROEL | mitochondrial matrix protein P1 | CPN60 | HLD4

Targeting HSPD1: A Promising Approach To Neuroscience and Medicine

HSPD1 (Mitochondrial matrix protein P1) is a protein that is expressed in high levels in the mitochondria, which are organelles that are responsible for generating energy in the cell through a process called cellular respiration. Mitochondria are also responsible for manufacturing the majority of the proteins that are essential for life, so it is important that they function properly in order to maintain cellular health. HSPD1 is a protein that is known to be expressed in the mitochondria and is involved in a number of cellular processes that are important for overall cellular health.

One of the key functions of HSPD1 is its role in maintaining the stability of the mitochondria. The mitochondria are known for their ability to import and export various proteins, including HSPD1, which is involved in the import of proteins into the mitochondria. This is important for maintaining the proper structure and function of the mitochondria, as well as for ensuring that they are able to produce the proteins that are necessary for cellular respiration.

Another function of HSPD1 is its role in the regulation of cellular processes that are important for overall cellular health. For example, HSPD1 has been shown to be involved in the production of reactive oxygen species (ROS), which can damage cellular components and contribute to the development of a variety of diseases. By regulating the production of ROS, HSPD1 may be able to help prevent the damage that can be caused by these reactive molecules.

In addition to its role in maintaining the stability of the mitochondria and regulating cellular processes, HSPD1 is also thought to be involved in the production of various proteins that are important for the development and maintenance of the nervous system. For example, HSPD1 has been shown to be involved in the production of neurotransmitter-producing proteins, which are important for the proper functioning of the nervous system.

Despite the importance of HSPD1 in numerous cellular processes, much more research is needed about its role in the cell. In particular, there is a need for more research about the precise mechanisms by which HSPD1 functions in the mitochondria and the body as a whole.

Targeting HSPD1 as a drug or biomarker
Given the importance of HSPD1 in numerous cellular processes, there is a growing interest in targeting this protein as a potential drug or biomarker. One approach that is being explored for targeting HSPD1 is the use of small molecules, such as drugs that can modulate the activity of HSPD1. These small molecules can be designed to specifically interact with HSPD1 and alter its function in the cell.

Another approach that is being explored for targeting HSPD1 is the use of antibodies, such as monoclonal antibodies (MCAs). MCAs are laboratory-produced molecules that are designed to recognize and bind to a specific protein, such as HSPD1. These antibodies can be used to selectively target HSPD1 in the cell and can be used for a variety of different applications, such as diagnostic tests or therapeutic treatments.

In addition to the use of small molecules and antibodies, there is also interest in the use of genetic modification to alter the expression of HSPD1. This can be done by introducing changes to the DNA sequence of HSPD1, which will alter the way that the protein is produced and may affect its function in the cell.

Overall, targeting HSPD1 as a drug or biomarker is an promising approach that has the potential to lead to new and exciting developments in the field of neuroscience and medicine. Further research is needed to fully understand the role of HSPD1 in the cell and to develop effective strategies for targeting this protein.

Protein Name: Heat Shock Protein Family D (Hsp60) Member 1

Functions: Chaperonin implicated in mitochondrial protein import and macromolecular assembly. Together with Hsp10, facilitates the correct folding of imported proteins. May also prevent misfolding and promote the refolding and proper assembly of unfolded polypeptides generated under stress conditions in the mitochondrial matrix (PubMed:1346131, PubMed:11422376). The functional units of these chaperonins consist of heptameric rings of the large subunit Hsp60, which function as a back-to-back double ring. In a cyclic reaction, Hsp60 ring complexes bind one unfolded substrate protein per ring, followed by the binding of ATP and association with 2 heptameric rings of the co-chaperonin Hsp10. This leads to sequestration of the substrate protein in the inner cavity of Hsp60 where, for a certain period of time, it can fold undisturbed by other cell components. Synchronous hydrolysis of ATP in all Hsp60 subunits results in the dissociation of the chaperonin rings and the release of ADP and the folded substrate protein (Probable)

The "HSPD1 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about HSPD1 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

HSPD1P11 | HSPD1P2 | HSPD1P3 | HSPD1P5 | HSPD1P8 | HSPD1P9 | HSPE1 | HSPE1-MOB4 | HSPE1P8 | HSPG2 | HSPH1 | HTATIP2 | HTATSF1 | HTATSF1P2 | HTD2 | HTN1 | HTN3 | HTR1A | HTR1D | HTR1E | HTR1F | HTR2A | HTR2A-AS1 | HTR2B | HTR2C | HTR3A | HTR3B | HTR3C | HTR3D | HTR3E | HTR3E-AS1 | HTR4 | HTR5A | HTR5A-AS1 | HTR5BP | HTR6 | HTR7 | HTR7P1 | HTRA1 | HTRA2 | HTRA3 | HTRA4 | HTT | HTT-AS | HULC | Human chorionic gonadotropin | HUNK | HUS1 | HUS1B | HUWE1 | HVCN1 | HYAL1 | HYAL2 | HYAL3 | HYAL4 | HYAL6P | Hyaluronidase | HYCC1 | HYCC2 | HYDIN | HYI | HYKK | HYLS1 | HYMAI | HYOU1 | HYPK | Hypoxia inducible factor (HIF) | Hypoxia-Inducible Factor Prolyl Hydroxylase | I-kappa-B-kinase (IKK) complex | IAH1 | IAPP | IARS1 | IARS2 | IATPR | IBA57 | IBA57-DT | IBSP | IBTK | ICA1 | ICA1L | ICAM1 | ICAM2 | ICAM3 | ICAM4 | ICAM5 | ICE1 | ICE2 | ICMT | ICMT-DT | ICOS | ICOSLG | ID1 | ID2 | ID2-AS1 | ID2B | ID3 | ID4 | IDE | IDH1 | IDH1-AS1